SHERWIN STEPHEN A
Insider CIK 1079462 · BPAX Director · RIGL Director · ADRO Director · VSTM Director · NTGN Director · VICL Director · BIIB Director · NBIX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NBIX NEUROCRINE BIOSCIENCES INC | G Gift | 2026-09-02 | 2026-09-03 | 1,000 | — | $0 | 14,860 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | G Gift | 2026-09-02 | 2026-09-03 | 1,000 | — | $0 | 14,860 | SEC↗ |
| BIIB BIOGEN INC. | A Award | 2026-06-09 | 2026-06-11 | 1,505 | — | $0 | 15,193 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2026-06-05 | 2026-06-09 | 15,000 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2026-06-05 | 2026-06-09 | 10,000 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2026-06-05 | 2026-06-09 | 1,843 | $167.31 | $308.4K | 15,860 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2026-06-05 | 2026-06-09 | 5,829 | $166.56 | $970.9K | 17,703 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2026-06-05 | 2026-06-09 | 6,896 | $165.79 | $1.14M | 23,532 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2026-06-05 | 2026-06-09 | 2,549 | $164.44 | $419.2K | 30,428 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2026-06-05 | 2026-06-09 | 7,883 | $163.81 | $1.29M | 32,977 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2026-06-05 | 2026-06-09 | 10,000 | $79.79 | $797.9K | 40,860 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2026-06-05 | 2026-06-09 | 15,000 | $53.64 | $804.6K | 30,860 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2026-05-27 | 2026-05-29 | 2,567 | — | $0 | 2,567 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2026-05-21 | 2026-05-21 | 3,318 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2026-05-21 | 2026-05-21 | 3,318 | — | $0 | 15,860 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | G Gift | 2025-09-02 | 2025-09-03 | 1,000 | — | $0 | 12,542 | SEC↗ |
| BIIB BIOGEN INC. | A Award | 2025-06-17 | 2025-06-18 | 2,370 | — | $0 | 13,688 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2025-05-22 | 2025-05-22 | 2,869 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2025-05-22 | 2025-05-22 | 2,869 | — | $0 | 13,542 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2025-05-21 | 2025-05-22 | 3,318 | — | $0 | 3,318 | SEC↗ |
| BIIB BIOGEN INC. | S Sale | 2025-03-07 | 2025-03-10 | 8,760 | $150.02 | $1.31M | 11,318 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2025-02-13 | 2025-02-14 | 13,831 | $116.69 | $1.61M | 10,673 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | G Gift | 2024-11-04 | 2024-11-07 | 2,000 | — | $0 | 24,504 | SEC↗ |
| BIIB BIOGEN INC. | A Award | 2024-06-21 | 2024-06-25 | 1,340 | — | $0 | 20,078 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2024-05-29 | 2024-05-30 | 25,000 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2024-05-29 | 2024-05-30 | 15,000 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2024-05-29 | 2024-05-30 | 15,000 | $47.89 | $718.4K | 41,504 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-05-29 | 2024-05-30 | 25,000 | $133.46 | $3.34M | 26,504 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-05-29 | 2024-05-30 | 15,000 | $133.47 | $2.00M | 26,504 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2024-05-29 | 2024-05-30 | 25,000 | $42.76 | $1.07M | 51,504 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2024-05-22 | 2024-05-23 | 2,869 | — | $0 | 2,869 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2024-05-17 | 2024-05-21 | 4,199 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2024-05-17 | 2024-05-21 | 4,199 | — | $0 | 26,504 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | G Gift | 2023-11-16 | 2023-11-20 | 2,750 | — | $0 | 22,305 | SEC↗ |
| BIIB BIOGEN INC. | A Award | 2023-06-26 | 2023-06-28 | 960 | — | $0 | 18,738 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2023-05-17 | 2023-05-19 | 4,199 | — | $0 | 4,199 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2023-01-03 | 2023-01-05 | 15,000 | $12.71 | $190.7K | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2023-01-03 | 2023-01-05 | 15,000 | $12.98 | $194.7K | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2023-01-03 | 2023-01-05 | 15,000 | $12.98 | $194.7K | 40,055 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2023-01-03 | 2023-01-05 | 15,000 | $12.71 | $190.7K | 40,055 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-01-03 | 2023-01-05 | 15,000 | $118.85 | $1.78M | 25,055 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-01-03 | 2023-01-05 | 15,000 | $118.87 | $1.78M | 25,055 | SEC↗ |
| BIIB BIOGEN INC. | A Award | 2022-06-15 | 2022-06-17 | 1,370 | — | $0 | 18,473 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2022-05-18 | 2022-05-20 | 9,724 | — | $0 | 9,724 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2022-01-24 | 2022-01-26 | 15,000 | $6.66 | $99.9K | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2022-01-24 | 2022-01-26 | 15,000 | $74.43 | $1.12M | 25,055 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2022-01-24 | 2022-01-26 | 15,000 | $6.66 | $99.9K | 40,055 | SEC↗ |
| NBIX | G Gift | 2021-12-14 | 2021-12-16 | 2,000 | — | $0 | 25,055 | SEC↗ |
| BIIB BIOGEN INC. | A Award | 2021-07-01 | 2021-07-02 | 775 | — | $0 | 17,103 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2021-05-19 | 2021-05-20 | 8,833 | — | $0 | 8,833 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | G Gift | 2020-12-03 | 2020-12-07 | 2,806 | — | $0 | 27,055 | SEC↗ |
| BIIB BIOGEN INC. | A Award | 2020-06-03 | 2020-06-05 | 890 | — | $0 | 16,328 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2020-05-19 | 2020-05-21 | 6,018 | — | $0 | 6,018 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | D To issuer deriv | 2020-05-06 | 2020-05-06 | 18,500 | — | $0 | 0 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | D To issuer deriv | 2020-05-06 | 2020-05-06 | 5,000 | — | $0 | 0 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | D To issuer deriv | 2020-05-06 | 2020-05-06 | 14,000 | — | $0 | 0 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | D To issuer | 2020-05-06 | 2020-05-06 | 45,000 | — | $0 | 0 | SEC↗ |
| ADRO ADURO BIOTECH, INC. | A Award deriv | 2020-05-05 | 2020-05-28 | 30,000 | — | $0 | 30,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2020-04-28 | 2020-04-30 | 17,687 | $99.39 | $1.76M | 29,861 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2020-03-11 | 2020-03-12 | 10,923 | — | $0 | 0 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2020-03-11 | 2020-03-12 | 1,355 | — | $0 | 0 | SEC↗ |
| BIIB BIOGEN INC. | S Sale | 2020-03-11 | 2020-03-12 | 2,164 | $295.22 | $638.9K | 14,353 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2020-03-11 | 2020-03-12 | 1,355 | $58.46 | $79.2K | 15,708 | SEC↗ |
| BIIB BIOGEN INC. | S Sale | 2020-03-11 | 2020-03-12 | 270 | $295.29 | $79.7K | 15,438 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2020-03-11 | 2020-03-12 | 10,923 | $58.46 | $638.6K | 16,517 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | A Award deriv | 2019-06-25 | 2019-06-27 | 18,500 | — | $0 | 18,500 | SEC↗ |
| BIIB BIOGEN INC. | A Award | 2019-06-19 | 2019-06-20 | 1,155 | — | $0 | 6,319 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2019-05-22 | 2019-05-23 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ADRO ADURO BIOTECH, INC. | A Award deriv | 2019-05-14 | 2019-05-15 | 30,000 | — | $0 | 30,000 | SEC↗ |
| BIIB BIOGEN INC. | G Gift | 2018-10-31 | 2018-11-05 | 200 | — | $0 | 5,339 | SEC↗ |
| BIIB BIOGEN INC. | G Gift | 2018-10-31 | 2018-11-05 | 175 | — | $0 | 5,164 | SEC↗ |
| BIIB BIOGEN INC. | G Gift | 2018-10-31 | 2018-11-05 | 275 | — | $0 | 5,739 | SEC↗ |
| BIIB BIOGEN INC. | G Gift | 2018-10-31 | 2018-11-05 | 200 | — | $0 | 5,539 | SEC↗ |
| BIIB BIOGEN INC. | A Award | 2018-06-12 | 2018-06-14 | 880 | — | $0 | 6,014 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2018-06-11 | 2018-06-13 | 10,000 | $98.44 | $984.4K | 47,548 | SEC↗ |
| ADRO ADURO BIOTECH, INC. | A Award deriv | 2018-06-06 | 2018-06-08 | 20,000 | — | $0 | 20,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2018-05-24 | 2018-05-25 | 12,500 | — | $0 | 12,500 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2018-04-26 | 2018-04-30 | 15,000 | $7.05 | $105.8K | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2018-04-26 | 2018-04-30 | 15,000 | $7.05 | $105.8K | 58,879 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2018-04-26 | 2018-04-30 | 1,331 | $79.44 | $105.7K | 57,548 | SEC↗ |
| BIIB BIOGEN INC. | G Gift | 2017-11-29 | 2017-12-05 | 400 | — | $0 | 5,134 | SEC↗ |
| BIIB BIOGEN INC. | G Gift | 2017-11-29 | 2017-12-05 | 200 | — | $0 | 5,534 | SEC↗ |
| BIIB BIOGEN INC. | G Gift | 2017-11-29 | 2017-12-05 | 250 | — | $0 | 5,734 | SEC↗ |
| ADRO ADURO BIOTECH, INC. | A Award deriv | 2017-06-08 | 2017-06-12 | 13,000 | — | $0 | 13,000 | SEC↗ |
| BIIB BIOGEN INC. | A Award | 2017-06-07 | 2017-06-09 | 1,055 | — | $0 | 5,984 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2017-05-22 | 2017-06-08 | 15,000 | — | $0 | 15,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2017-02-07 | 2017-02-08 | 15,000 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2017-02-07 | 2017-02-08 | 15,000 | $3.40 | $51.0K | 45,048 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2017-02-07 | 2017-02-08 | 1,169 | $43.60 | $51.0K | 43,879 | SEC↗ |
| BIIB BIOGEN INC. | G Gift | 2016-11-08 | 2016-11-14 | 1,000 | — | $0 | 4,905 | SEC↗ |
| ADRO ADURO BIOTECH, INC. | A Award deriv | 2016-06-09 | 2016-06-10 | 13,000 | — | $0 | 13,000 | SEC↗ |
| BIIB BIOGEN INC. | A Award | 2016-06-08 | 2016-06-09 | 1,060 | — | $0 | 5,905 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2016-05-20 | 2016-05-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2016-05-11 | 2016-05-12 | 40,000 | — | $0 | 40,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2016-04-14 | 2016-04-18 | 15,000 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2016-04-14 | 2016-04-18 | 15,000 | $3.07 | $46.0K | 31,030 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2016-04-14 | 2016-04-18 | 982 | $46.86 | $46.0K | 30,048 | SEC↗ |
| ADRO ADURO BIOTECH, INC. | A Award deriv | 2015-06-25 | 2015-06-26 | 15,000 | — | $0 | 15,000 | SEC↗ |
| VSTM Verastem, Inc. | A Award deriv | 2015-06-12 | 2015-06-16 | 17,969 | — | $0 | 17,969 | SEC↗ |
| BIIB BIOGEN INC. | A Award | 2015-06-10 | 2015-06-11 | 695 | — | $0 | 4,845 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2015-05-28 | 2015-06-01 | 25,000 | — | $0 | 25,000 | SEC↗ |
| VICL VICAL INC | A Award deriv | 2015-05-21 | 2015-05-26 | 50,000 | — | $0 | 50,000 | SEC↗ |
| VICL VICAL INC | A Award | 2015-05-21 | 2015-05-26 | 7,500 | $0.01 | $75 | 22,003 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2015-05-13 | 2015-05-14 | 40,000 | — | $0 | 40,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2015-04-07 | 2015-04-09 | 15,000 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2015-04-07 | 2015-04-09 | 15,000 | $4.76 | $71.4K | 17,806 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2015-04-07 | 2015-04-09 | 1,776 | $40.20 | $71.4K | 16,030 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2015-03-10 | 2015-03-11 | 6,000 | — | $0 | 10,675 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2015-03-10 | 2015-03-11 | 6,000 | $59.82 | $358.9K | 10,150 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2015-03-10 | 2015-03-11 | 6,000 | $409.67 | $2.46M | 4,150 | SEC↗ |
| BIIB BIOGEN IDEC INC. | G Gift | 2015-03-06 | 2015-03-11 | 275 | — | $0 | 4,150 | SEC↗ |
| VSTM Verastem, Inc. | P Buy | 2014-12-26 | 2014-12-29 | 2,500 | $8.56 | $21.4K | 2,500 | SEC↗ |
| BIIB BIOGEN IDEC INC. | G Gift | 2014-12-01 | 2014-12-03 | 405 | — | $0 | 4,425 | SEC↗ |
| BIIB BIOGEN IDEC INC. | A Award | 2014-06-12 | 2014-06-16 | 870 | — | $0 | 4,830 | SEC↗ |
| VSTM Verastem, Inc. | A Award deriv | 2014-06-10 | 2014-06-11 | 25,000 | — | $0 | 25,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2014-05-22 | 2014-05-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| VICL VICAL INC | A Award deriv | 2014-05-22 | 2014-05-23 | 50,000 | — | $0 | 50,000 | SEC↗ |
| VICL VICAL INC | A Award | 2014-05-22 | 2014-05-23 | 7,500 | $0.01 | $75 | 14,503 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2014-05-21 | 2014-05-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2014-04-16 | 2014-04-18 | 12,000 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2014-04-16 | 2014-04-18 | 12,000 | $12.37 | $148.4K | 13,531 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2014-04-16 | 2014-04-18 | 10,725 | $13.84 | $148.4K | 2,806 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2014-01-02 | 2014-01-06 | 5,500 | — | $0 | 16,675 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2014-01-02 | 2014-01-06 | 5,500 | $59.82 | $329.0K | 9,460 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2014-01-02 | 2014-01-06 | 3,700 | $279.50 | $1.03M | 3,960 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2014-01-02 | 2014-01-06 | 1,800 | $278.84 | $501.9K | 7,660 | SEC↗ |
| BIIB BIOGEN IDEC INC. | A Award | 2013-06-12 | 2013-06-13 | 1,305 | — | $0 | 3,960 | SEC↗ |
| VSTM Verastem, Inc. | A Award deriv | 2013-06-04 | 2013-06-06 | 3,116 | — | $0 | 3,116 | SEC↗ |
| VSTM Verastem, Inc. | A Award deriv | 2013-06-04 | 2013-06-06 | 12,500 | — | $0 | 12,500 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2013-06-03 | 2013-06-04 | 12,825 | — | $0 | 22,175 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-06-03 | 2013-06-04 | 3,433 | $232.51 | $798.2K | 12,047 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-06-03 | 2013-06-04 | 9,392 | $233.54 | $2.19M | 2,655 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2013-06-03 | 2013-06-04 | 12,825 | $59.82 | $767.2K | 15,480 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2013-05-23 | 2013-05-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| VICL VICAL INC | A Award deriv | 2013-05-23 | 2013-05-28 | 40,176 | — | $0 | 40,176 | SEC↗ |
| VICL VICAL INC | P Buy | 2013-05-23 | 2013-05-28 | 7,003 | $0.01 | $70 | 7,003 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2013-05-15 | 2013-05-28 | 15,000 | — | $0 | 15,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2013-03-28 | 2013-04-01 | 12,000 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2013-03-28 | 2013-04-01 | 12,000 | $10.60 | $127.2K | 12,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2013-03-28 | 2013-04-01 | 10,469 | $12.15 | $127.2K | 1,531 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-03-22 | 2013-03-25 | 1,500 | $176.88 | $265.3K | 2,655 | SEC↗ |
| VSTM Verastem, Inc. | A Award deriv | 2013-03-05 | 2013-03-06 | 25,000 | — | $0 | 25,000 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2012-09-04 | 2012-09-05 | 2,000 | $145.90 | $291.8K | 4,155 | SEC↗ |
| BIIB BIOGEN IDEC INC. | A Award | 2012-06-08 | 2012-06-11 | 2,020 | — | $0 | 6,155 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2012-06-04 | 2012-06-05 | 2,500 | $126.45 | $316.1K | 4,135 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2012-05-23 | 2012-05-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2012-05-23 | 2012-05-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BPAX BIOSANTE PHARMACEUTICALS I | A Award deriv | 2012-03-30 | 2012-03-30 | 25,000 | — | $0 | 25,000 | SEC↗ |